England is testing a new artificial intelligence (AI) tool to speed prostate cancer diagnoses, which may save men from weeks of uncertainty about their health. The tool, which will be piloted through ...

News of the study comes days after it emerged an NHS trial will use AI to interpret MRI scans from men suspected of having ...

BRAMPTON, ON, Sept. 3, 2014 /CNW/ - Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce its "Together We Are Stronger" campaign that seeks to help eliminate ...

HALIFAX – Canadian proponents of PSA blood testing say it remains a critical diagnostic tool for prostate cancer despite criticism that it may do more harm than good. Last week, a committee of ...

Thanks to early detection and aggressive treatment for prostate cancer, 97 percent of all men diagnosed with the disease will survive at least 5 years and nearly 80 percent will survive at least a ...

The MRI test does not need any injection, radiation or help from a doctor Author of the article: You can save this article by registering for free here. Or sign-in if you have an account. A new ...

HOUSTON, Texas, Jan. 05, 2021 (GLOBE NEWSWIRE) -- C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. (NYSE American: ISR) has received U.S. Food and Drug Administration (FDA) 510(k) ...

Pfizer’s ongoing study could significantly impact its stock performance, as positive results may enhance investor confidence and market position in the competitive prostate cancer treatment landscape.

HALIFAX – Canadian proponents of PSA blood testing say it remains a critical diagnostic tool for prostate cancer despite criticism that it may do more harm than good. Last week, a committee of ...